Carvolix: Voting rights status as of July 31, 2026

Carvolix, a company listed on Euronext Paris, has released information on its share capital structure as of July 31, 2026. The company's share capital amounts to €6,227,517.07, divided into 62,275,177 shares. The total theoretical voting rights are 90,533,664, while the exercisable voting rights total 90,494,912. These figures comply with the French Commercial Code and the regulations of the French Financial Markets Authority (AMF). Carvolix is committed to providing clear information regarding its corporate governance.

Carvolix, a specialist in medical technologies, continues its ambition to become a major player in the treatment of heart disease. The company is relying on its innovations to simplify interventional procedures.